NYSE:CVS - CVS Health Stock Price, Price Target & More

$68.69 +0.96 (+1.42 %)

(As of 04/26/2018 04:00 PM ET)

Previous Close$67.73

Today's Range$67.70 - $69.3750

52-Week Range$60.14 - $84.00

Volume10.66 million shs

Average Volume8.61 million shs

Market Capitalization$67.57 billion

P/E Ratio11.64

Dividend Yield3.00%

Beta1.05

About CVS Health (NYSE:CVS)

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores

Sub-IndustryDrug Retail

SectorRetail/Wholesale

SymbolNYSE:CVS

CUSIP12665010

Webwww.cvshealth.com

Phone401-765-1500

Debt

Debt-to-Equity Ratio0.59%

Current Ratio1.02%

Quick Ratio0.52%

Price-To-Earnings

Trailing P/E Ratio11.64

Forward P/E Ratio10.87

P/E Growth1.13

Sales & Book Value

Annual Sales$184.77 billion

Price / Sales0.38

Cash Flow$8.8632 per share

Price / Cash7.75

Book Value$37.21 per share

Price / Book1.85

Profitability

EPS (Most Recent Fiscal Year)$5.90

Net Income$6.62 billion

Net Margins3.58%

Return on Equity17.21%

Return on Assets6.48%

Miscellaneous

Employees246,000

Outstanding Shares1,014,530,000

How to Become a New Pot Stock Millionaire

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Tuesday, March 13th. Shareholders of record on Monday, April 23rd will be given a dividend of $0.50 per share on Thursday, May 3rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.91%. The ex-dividend date is Friday, April 20th. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health (NYSE:CVS) issued its quarterly earnings results on Thursday, February, 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping the consensus estimate of $1.88 by $0.04. The pharmacy operator earned $48.39 billion during the quarter, compared to the consensus estimate of $47.54 billion. CVS Health had a return on equity of 17.21% and a net margin of 3.58%. The business's quarterly revenue was up 5.3% on a year-over-year basis. During the same quarter last year, the firm earned $1.71 earnings per share. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, May, 2nd 2018. View Earnings Estimates for CVS Health.

What price target have analysts set for CVS?

20 brokers have issued twelve-month price targets for CVS Health's stock. Their forecasts range from $73.00 to $99.00. On average, they expect CVS Health's stock price to reach $87.2353 in the next twelve months. View Analyst Ratings for CVS Health.

Are investors shorting CVS Health?

CVS Health saw a increase in short interest in April. As of April 13th, there was short interest totalling 43,345,137 shares, an increase of 3.2% from the March 30th total of 41,995,032 shares. Based on an average daily trading volume, of 6,785,792 shares, the short-interest ratio is presently 6.4 days. Currently, 4.3% of the company's stock are sold short.

Who are some of CVS Health's key competitors?

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Express Scripts (ESRX), Rite Aid (RAD), Diplomat Pharmacy (DPLO), 1-800-PetMeds (PETS), Taxus Pharmaceuticals (TXSP), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:

Mr. Larry J. Merlo, Pres, CEO & Director (Age 62)
Mr. David M. Denton, Exec. VP & CFO (Age 53)
Mr. Jonathan C. Roberts, Exec. VP & COO (Age 62)
Mr. Thomas Michael Moriarty, Exec. VP, Gen. Counsel and Chief of Policy & External Affairs Officer (Age 54)
Ms. Eva C. Boratto, Exec. VP, Controller & Chief Accounting Officer (Age 51)

Has CVS Health been receiving favorable news coverage?

News stories about CVS stock have trended somewhat positive this week, according to Accern Sentiment. Accern scores the sentiment of press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CVS Health earned a news impact score of 0.15 on Accern's scale. They also assigned media stories about the pharmacy operator an impact score of 45.97 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the near term.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $68.69.

How big of a company is CVS Health?

CVS Health has a market capitalization of $67.57 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]

MarketBeat Community Rating for CVS Health (CVS)

Community Ranking:		3.4 out of 5 ( )
Outperform Votes:		940 (Vote Outperform)
Underperform Votes:		435 (Vote Underperform)
Total Votes:		1,375

MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.

CVS Health (NYSE:CVS) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

20 Wall Street analysts have issued ratings and price targets for CVS Health in the last 12 months. Their average twelve-month price target is $87.2353, suggesting that the stock has a possible upside of 27.00%. The high price target for CVS is $99.00 and the low price target for CVS is $73.00. There are currently 6 hold ratings, 12 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.80	2.80	2.76	2.64
Ratings Breakdown:	0 Sell Rating(s) 6 Hold Rating(s) 12 Buy Rating(s) 2 Strong Buy Rating(s)	0 Sell Rating(s) 6 Hold Rating(s) 12 Buy Rating(s) 2 Strong Buy Rating(s)	0 Sell Rating(s) 7 Hold Rating(s) 12 Buy Rating(s) 2 Strong Buy Rating(s)	0 Sell Rating(s) 8 Hold Rating(s) 14 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$87.2353	$87.5789	$88.0335	$87.93
Price Target Upside:	27.00% upside	28.36% upside	9.44% upside	19.94% upside

CVS Health (NYSE:CVS) Consensus Price Target History

Price Target History for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
4/11/2018	Bank of America	Lower Price Target	Buy -> Buy	$91.00 -> $88.00	Low
4/10/2018	Leerink Swann	Set Price Target	Buy	$85.00	Low
2/13/2018	Citigroup	Set Price Target	Neutral -> Neutral	$80.00 -> $77.00	Low
2/9/2018	Robert W. Baird	Lower Price Target	Neutral -> Neutral	$85.00 -> $80.00	Low
2/9/2018	Needham & Company LLC	Set Price Target	Strong-Buy -> Buy	$100.00 -> $98.00	Medium
2/8/2018	Royal Bank of Canada	Set Price Target	Buy	$89.00	Medium
1/24/2018	Mizuho	Set Price Target	Buy	$95.00	Low
1/18/2018	Cowen	Reiterated Rating	Outperform	$81.00 -> $99.00	Low
1/5/2018	SunTrust Banks	Boost Price Target	Buy	$90.00	High
1/5/2018	Morgan Stanley	Upgrade	Equal Weight -> Overweight	$88.00	High
1/4/2018	Raymond James	Upgrade	Outperform -> Strong-Buy	$90.00	High
1/4/2018	UBS	Upgrade	Outperform -> Strong-Buy		High
12/26/2017	Tigress Financial	Reiterated Rating	Buy		Low
12/5/2017	Deutsche Bank	Reiterated Rating	Buy -> Hold		Medium
12/4/2017	Jefferies Group	Set Price Target	Hold	$76.00	Medium
12/4/2017	Loop Capital	Set Price Target	Hold	$73.00	Medium
10/9/2017	Oppenheimer	Reiterated Rating	Buy	$95.00	N/A
8/14/2017	Wolfe Research	Downgrade	Outperform -> Market Perform	$89.00 -> $82.00	Low
7/3/2017	Guggenheim	Reiterated Rating	Buy		Low
5/3/2017	Evercore ISI	Reiterated Rating	Outperform	$87.00 -> $88.00	Low
2/6/2017	Atlantic Securities	Downgrade	Overweight -> Neutral	$84.00	N/A
12/19/2016	Credit Suisse Group	Reiterated Rating	Buy		N/A
11/10/2016	Argus	Reiterated Rating	Buy	$120.00 -> $85.00	N/A
11/9/2016	Barclays	Reiterated Rating	Buy	$85.00	N/A
8/3/2016	FBR & Co	Reiterated Rating	Outperform	$120.00	N/A
5/5/2016	Macquarie	Reiterated Rating	Outperform	$115.00	N/A

(Data available from 4/26/2016 forward)

CVS Health (NYSE:CVS) Earnings History and Estimates Chart

Earnings by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Earnings Estimates

2018 EPS Consensus Estimate: $6.44

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	5	$1.10	$1.49	$1.29
Q2 2018	5	$1.43	$1.63	$1.56
Q3 2018	4	$1.32	$1.91	$1.62
Q4 2018	4	$1.93	$1.99	$1.97
Q1 2019	2	$1.06	$1.24	$1.15
Q2 2019	2	$1.26	$1.59	$1.43
Q3 2019	1	$1.43	$1.43	$1.43

CVS Health (NYSE CVS) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/2/2018		$1.34					N/A
2/8/2018	Q4 2017	$1.88	$1.92	$47.5388 billion	$48.3850 billion	View	Listen
11/6/2017	Q3 2017	$1.49	$1.50	$46.1740 billion	$46.1810 billion	View	N/A
8/8/2017	Q2 2017	$1.31	$1.33	$45.3553 billion	$45.6850 billion	View	Listen
5/2/2017	Q1 2017	$1.1030	$1.17	$44.2025 billion	$44.5140 billion	View	Listen
2/9/2017	Q416	$1.67	$1.71	$46.56 billion	$46.00 billion	View	Listen
11/8/2016	Q316	$1.57	$1.64	$45.29 billion	$44.60 billion	View	Listen
8/2/2016	Q216	$1.30	$1.32	$44.28 billion	$43.70 billion	View	N/A
5/3/2016	Q116	$1.16	$1.18	$43.01 billion	$43.20 billion	View	N/A
2/9/2016	Q415	$1.53	$1.53	$41.12 billion	$41.15 billion	View	N/A
10/30/2015	Q315	$1.29	$1.28	$37.81 billion	$38.50 billion	View	Listen
8/4/2015	Q215	$1.20	$1.22	$37.18 billion	$37.20 billion	View	N/A
5/1/2015	Q115	$1.08	$1.14	$35.93 billion	$36.30 billion	View	N/A
2/10/2015	Q414	$1.21	$1.21	$36.06 billion	$37.06 billion	View	N/A
11/4/2014	Q314	$1.13	$1.15	$34.74 billion	$35.00 billion	View	N/A
8/5/2014	Q214	$1.10	$1.13	$33.47 billion	$34.60 billion	View	N/A
5/2/2014	Q114	$1.05	$1.02	$32.31 billion	$32.70 billion	View	N/A
2/11/2014	Q413	$1.11	$1.12	$32.67 million	$32.80 million	View	N/A
11/5/2013	Q313	$1.02	$1.05	$31.53 billion	$32.00 billion	View	Listen
8/6/2013	Q2 2013	$0.96	$0.97	$31.13 billion	$31.25 billion	View	Listen
5/1/2013	Q113	$0.79	$0.83	$30.36 billion	$30.76 billion	View	Listen
2/6/2013	Q4 2012	$1.10	$1.14	$31.13 billion	$31.40 billion	View	Listen
11/6/2012	Q312	$0.84	$0.85	$30.0880 billion	$30.2270 billion	View	N/A
8/7/2012		$0.80	$0.81			View	N/A
5/2/2012		$0.63	$0.65			View	N/A
2/8/2012	Q4 2011	$0.89	$0.89			View	N/A
11/3/2011		$0.68	$0.70			View	N/A
8/4/2011		$0.65	$0.65			View	N/A
5/5/2011		$0.55	$0.57			View	N/A
2/3/2011		$0.79	$0.80			View	N/A
11/3/2010	Q3 2010	$0.64	$0.65			View	N/A
7/28/2010	Q2 2010	$0.68	$0.65			View	N/A
5/4/2010	Q1 2010	$0.58	$0.60			View	N/A
2/8/2010	Q4 2009	$0.78	$0.79			View	N/A
11/5/2009	Q3 2009	$0.64	$0.65			View	N/A
8/4/2009	Q2 2009	$0.64	$0.65			View	N/A
5/5/2009	Q1 2009	$0.54	$0.55			View	N/A
2/19/2009	Q4 2008	$0.69	$0.70			View	N/A
10/30/2008	Q3 2008	$0.59	$0.60			View	N/A
7/31/2008	Q2 2008	$0.60	$0.60			View	N/A
5/1/2008	Q1 2008	$0.54	$0.55			View	N/A
1/31/2008	Q4 2007	$0.55	$0.58			View	N/A

(Earnings results data provided by Zacks Investment Research)

CVS Health (NYSE:CVS) Dividend Information

CVS Health pays an annual dividend of $2.00 per share, with a dividend yield of 2.91%. CVS's next quarterly dividend payment will be made on Thursday, May 3. The company has grown its dividend for the last 10 consecutive years and is increasing its dividend by an average of 22.10% each year. CVS Health pays out 33.90% of its earnings out as a dividend.

Next Dividend:	5/3/2018
Annual Dividend:	$2.00
Dividend Yield:	2.91%
Dividend Growth:	22.10% (3 Year Average)
Payout Ratio:	33.90% (Trailing 12 Months of Earnings) 31.65% (Based on This Year's Estimates) 29.63% (Based on Next Year's Estimates)
Track Record:	10 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE:CVS) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
3/13/2018	quarterly	$0.50	2.9655990510083%	4/20/2018	4/23/2018	5/3/2018
12/29/2017	quarterly	$0.50	2.72%	1/23/2018	1/24/2018	2/2/2018
9/19/2017	quarterly	$0.50	2.48%	10/23/2017	10/24/2017	11/3/2017
7/6/2017	quarterly	$0.50	2.54%	7/20/2017	7/24/2017	8/3/2017
3/2/2017	quarterly	$0.50	2.47%	4/19/2017	4/21/2017	5/1/2017
12/22/2016	quarterly	$0.50	2.54%	1/20/2017	1/24/2017	2/2/2017
9/22/2016	quarterly	$0.4250	1.88%	10/20/2016	10/24/2016	11/3/2016
7/6/2016	quarterly	$0.4250	1.78%	7/19/2016	7/21/2016	8/1/2016
3/2/2016	quarterly	$0.4250	1.71%	4/20/2016	4/22/2016	5/2/2016
12/16/2015	quarterly	$0.4250	1.79%	1/20/2016	1/22/2016	2/2/2016
10/1/2015	quarterly	$0.35	1.41%	10/20/2015	10/22/2015	11/2/2015
7/8/2015	quarterly	$0.35	1.32%	7/21/2015	7/23/2015	8/3/2015
3/4/2015	quarterly	$0.35	1.35%	4/22/2015	4/24/2015	5/4/2015
12/17/2014	quarterly	$0.35	1.49%	1/20/2015	1/22/2015	2/2/2015
9/24/2014	quarterly	$0.2750	1.38%	10/21/2014	10/23/2014	11/3/2014
7/10/2014	quarterly	$0.2750	1.43%	7/17/2014	7/21/2014	8/1/2014
3/6/2014	quarterly	$0.2750	1.5%	4/17/2014	4/22/2014	5/2/2014
12/18/2013	quarterly	$0.2750	1.57%	1/21/2014	1/23/2014	2/3/2014
9/25/2013	quarterly	$0.2250	1.55%	10/17/2013	10/21/2013	11/1/2013
7/10/2013	quarterly	$0.2250	1.48%	7/18/2013	7/22/2013	8/2/2013
3/6/2013	quarterly	$0.2250	1.73%	4/19/2013	4/23/2013	5/3/2013
12/13/2012	quarterly	$0.2250	1.83%	1/22/2013	1/24/2013	2/4/2013

(Data available from 1/1/2013 forward)

CVS Health (NYSE CVS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 0.61%
Institutional Ownership Percentage: 84.01%

Insider Trading History for CVS Health (NYSE:CVS)

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

CVS Health (NYSE CVS) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/16/2018	Helena Foulkes	EVP	Sell	19,965	$71.04	$1,418,313.60	65,072
12/21/2017	Lisa Bisaccia	EVP	Sell	29,445	$75.00	$2,208,375.00	15,556
10/2/2017	Thomas M Moriarty	EVP	Sell	20,547	$81.17	$1,667,799.99	43,178
9/18/2017	Jonathan C Roberts	COO	Sell	85,743	$83.14	$7,128,673.02	119,555
9/15/2017	Helena Foulkes	EVP	Sell	39,340	$81.88	$3,221,159.20	84,337
9/13/2017	Larry J Merlo	Insider	Sell	241,150	$83.07	$20,032,330.50	299,255
9/11/2017	David M Denton	CFO	Sell	237,078	$79.65	$18,883,262.70	141,096
9/11/2017	Thomas M Moriarty	EVP	Sell	90,267	$79.61	$7,186,155.87	70,102
8/16/2017	Richard J Swift	Director	Sell	2,500	$79.62	$199,050.00	3,258
6/26/2017	Helena Foulkes	EVP	Sell	20,333	$80.00	$1,626,640.00	59,301
6/19/2017	Helena Foulkes	EVP	Sell	20,332	$76.98	$1,565,157.36	59,300
6/12/2017	David M Denton	CFO	Sell	230,510	$80.00	$18,440,800.00	176,983
3/21/2017	Troyen A Brennan	EVP	Sell	23,849	$78.73	$1,877,631.77	94,309
3/17/2017	Eva C Boratto	EVP	Sell	6,029	$79.60	$479,908.40	41,614
3/13/2017	Andrew Sussman	EVP	Sell	14,104	$80.40	$1,133,961.60	22,801
3/10/2017	David M Denton	CFO	Sell	95,618	$80.68	$7,714,460.24	250,335
2/16/2017	Jonathan C Roberts	EVP	Sell	61,196	$80.00	$4,895,680.00	89,955
5/5/2016	Larry J Merlo	CEO	Sell	38,247	$105.00	$4,015,935.00	280,381
5/5/2016	Troyen A Brennan	EVP	Sell	7,517	$105.00	$789,285.00	69,601
4/1/2016	Stephen J Gold	EVP	Sell	21,922	$105.00	$2,301,810.00	42,048
3/9/2016	Larry J Merlo	CEO	Sell	38,247	$100.00	$3,824,700.00	261,287
2/11/2016	Jonathan C. Roberts	EVP	Sell	23,355	$92.86	$2,168,745.30	75,315
2/1/2016	Larry J. Merlo	CEO	Sell	46,393	$96.14	$4,460,223.02	561,059
1/11/2016	Larry J. Merlo	CEO	Sell	46,393	$95.00	$4,407,335.00	161,613
10/27/2015	Troyen A. Brennan	EVP	Sell	23,603	$105.00	$2,478,315.00	43,858
7/20/2015	Eva C Boratto	SVP	Sell	22,107	$110.34	$2,439,286.38
7/15/2015	Lisa Bisaccia	EVP	Sell	49,908	$110.00	$5,489,880.00
6/1/2015	C David Brown II	Director	Sell	10,000	$102.57	$1,025,700.00
5/1/2015	C David Brown II	Director	Sell	15,000	$100.27	$1,504,050.00
4/10/2015	Andrew Sussman	EVP	Sell	17,638	$102.38	$1,805,778.44
4/2/2015	Troyen A Brennan	EVP	Sell	33,384	$102.48	$3,421,192.32
3/23/2015	Troyen A Brennan	EVP	Sell	33,274	$104.94	$3,491,773.56
3/20/2015	C David Brown II	Director	Sell	25,000	$104.30	$2,607,500.00
1/7/2015	Jonathan C Roberts	EVP	Sell	86,487	$95.31	$8,243,075.97
1/5/2015	Larry J Merlo	CEO	Sell	144,144	$94.30	$13,592,779.20
1/2/2015	Andrew Sussman	SVP	Sell	4,220	$95.67	$403,727.40
1/2/2015	Per Gh Lofberg	EVP	Sell	347,343	$95.28	$33,094,841.04
11/7/2014	Helena Foulkes	EVP	Sell	46,325	$88.06	$4,079,379.50
10/27/2014	Lisa Bisaccia	SVP	Sell	33,507	$85.00	$2,848,095.00
9/2/2014	Andrew Sussman	SVP	Sell	9,020	$79.45	$716,639.00
8/6/2014	J. David Joyner	EVP	Sell	123,516	$76.10	$9,399,567.60
7/21/2014	Eva C Boratto	SVP	Sell	22,107	$76.77	$1,697,154.39
7/1/2014	David M Denton	CFO	Sell	74,989	$75.88	$5,690,165.32
4/2/2014	Eva Boratto	SVP	Sell	17,108	$74.51	$1,274,717.08	6,998
3/31/2014	Troyen Brennan	EVP	Sell	18,867	$74.33	$1,402,384.11	56,187
1/3/2014	David Denton	CFO	Sell	14,113	$70.50	$994,966.50	85,869
1/3/2014	Per Gh Lofberg	EVP	Sell	790,888	$70.54	$55,789,239.52	219,871
1/2/2014	Jonathan Roberts	EVP	Sell	162,192	$70.61	$11,452,377.12	40,563
1/2/2014	Larry Merlo	CEO	Sell	228,875	$70.76	$16,195,195.00	408,649
12/10/2013	Lisa Bisaccia	SVP	Sell	12,057	$68.00	$819,876.00	27,233
11/18/2013	Troyen Brennan	EVP	Sell	35,387	$65.61	$2,321,741.07	56,187
10/18/2013	Eva C Boratto	SVP	Sell	11,053	$60.50	$668,706.50
10/11/2013	Eva Boratto	SVP	Sell	11,053	$59.50	$657,653.50	19,448
9/13/2013	Helena Foulkes	EVP	Sell	53,546	$60.00	$3,212,760.00	7,897
9/9/2013	Helena Foulkes	EVP	Sell	47,568	$58.65	$2,789,863.20
9/4/2013	Andrew Sussman	SVP	Sell	9,020	$58.36	$526,407.20	3,128
10/4/2012	Andrew Sussman	SVP	Sell	9,020	$49.00	$441,980.00
10/1/2012	Thomas M Moriarty	EVP	Buy	6,164	$48.67	$300,001.88
9/13/2012	David M Denton	CFO	Sell	11,526	$47.00	$541,722.00
8/21/2012	Jean Pierre Millon	Director	Sell	33,726	$45.73	$1,542,289.98

(Data available from 1/1/2013 forward)

CVS Health (NYSE CVS) News Headlines

Source:

Date	Headline
	CVS Health Underscores Commitment to Safe Medication Disposal Ahead of National Prescription Drug Take-Back Day on April 28 finance.yahoo.com - April 26 at 3:03 PM
	See what the IHS Markit Score report has to say about CVS Health Corp. finance.yahoo.com - April 26 at 3:03 PM
	Beauty isn't airbrushed in new CVS campaign www.bizjournals.com - April 25 at 3:10 PM
	Contrasting Diplomat Pharmacy (DPLO) & CVS Health (CVS) www.americanbankingnews.com - April 25 at 7:44 AM
	BRIEF-CVS Health Corp CEO's 2017 Compensation Was $12.25 Million www.reuters.com - April 25 at 5:02 AM
	CVS Health (CVS) Set to Announce Quarterly Earnings on Wednesday www.americanbankingnews.com - April 25 at 2:56 AM
	Should You Buy CVS Health Corporation (NYSE:CVS)? finance.yahoo.com - April 24 at 3:11 PM
	Factors Setting Stage For CVS Health's Q1 Earnings feeds.benzinga.com - April 24 at 12:49 PM
	Factors Setting Stage for CVS Health's (CVS) Q1 Earnings finance.yahoo.com - April 24 at 5:14 AM
	Factors Setting Stage for CVS Health's (CVS) Q1 Earnings finance.yahoo.com - April 24 at 5:14 AM
	Glenview's Robbins says talk of Amazon's entering pharma is overblown finance.yahoo.com - April 24 at 5:14 AM
	Humana, private-equity firms to buy hospice operator Curo Health for $1.4 billion www.cnbc.com - April 23 at 3:04 PM
	You can get rid of your unused medications at these drugstores finance.yahoo.com - April 23 at 3:04 PM
	Retail Clinics Are Not the Solution to Health Care www.nytimes.com - April 23 at 5:43 AM
	Longs Drugs opening Makaha store, preps to start on new Nanakuli shopping center finance.yahoo.com - April 21 at 5:02 AM
	CVS Pharmacy Offering Hepatitis A Vaccine to Kentuckians Following an Increase in Confirmed Cases of the Virus finance.yahoo.com - April 20 at 3:10 PM
	CVS reveals beauty campaign with unretouched images abcnews.go.com - April 20 at 3:10 PM
	Shift To ACA's Bronze Plans Could Boost CVS, Walgreens And Walmart Retail Clinics www.forbes.com - April 20 at 3:10 PM
	Shift To ACA's Bronze Plans Boosts CVS, Walgreens And Walmart Retail Clinics finance.yahoo.com - April 20 at 3:10 PM
	Leerink Swann Analysts Give CVS Health (CVS) a $90.00 Price Target www.americanbankingnews.com - April 20 at 3:01 PM
	CVS Health Corporation To Hold First Quarter 2018 Conference Call www.prnewswire.com - April 20 at 12:17 PM
	Phoenix VA Health Care System, TriWest and CVS Health Mark First Anniversary of Program that Expands Veterans ... www.prnewswire.com - April 20 at 5:15 AM
	For Now, Hospitals Hang On Despite CVS, Optum And Walmart Threats finance.yahoo.com - April 19 at 3:11 PM
	EX-Dividend Schedule: CVS Health Has a Dividend Yield of 3.03%; Will Trade Ex-Dividend on April 20, 2018 finance.yahoo.com - April 19 at 3:11 PM
	CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in Ohio to Help Combat Opioid Abuse finance.yahoo.com - April 19 at 3:11 PM
	CVS Pharmacy Launches First Campaign Featuring Unaltered Beauty Imagery finance.yahoo.com - April 19 at 3:11 PM
	Ex-Dividend Reminder: CVS Health, Interdigital and GEO Group www.nasdaq.com - April 18 at 3:11 PM
	Phoenix VA Health Care System, TriWest and CVS Health Mark First Anniversary of Program that Expands Veterans' Access to Health Care finance.yahoo.com - April 18 at 3:11 PM
	Cardinal Health stock up on news that Amazon will stay away from shipping drugs www.bizjournals.com - April 18 at 5:18 AM
	Aetna to reorganize ahead of CVS deal finance.yahoo.com - April 18 at 5:18 AM
	Aetna to hire 250 as part of 'innovation hub' expansion in Wellesley finance.yahoo.com - April 18 at 5:18 AM
	Why Did CVS Move Higher on April 16? finance.yahoo.com - April 17 at 3:15 PM
	Pharmacy Stocks Rise on News Amazon is Backing Off finance.yahoo.com - April 17 at 3:15 PM
	Rite Aid’s Top Line Fell for 4th Straight Quarter in Fiscal 4Q18 finance.yahoo.com - April 17 at 3:15 PM
	Moody's: Healthcare Quarterly looks at credit impact of planned mergers in US healthcare finance.yahoo.com - April 17 at 3:15 PM
	Pharmacy, health company stocks spike with news that Amazon will stay away from shipping drugs www.bizjournals.com - April 17 at 6:59 AM
	New retail chief at CVS Health seekingalpha.com - April 17 at 6:59 AM
	Why Are Walgreens and CVS Shares Surging Today? www.zacks.com - April 17 at 6:59 AM
	CVS Rallies After Amazon Report www.bloomberg.com - April 17 at 6:59 AM
	CVS Health (CVS) Stock Rating Lowered by BidaskClub www.americanbankingnews.com - April 16 at 7:00 PM
	Thinking about buying stock in Alkermes, Bank of America, CVS Health Corp, The Goldman Sachs Group and Tesla Motors www.bizjournals.com - April 16 at 3:19 PM
	Industry Moves: HBC Taps Another Woman From CVS for a Top Role www.msn.com - April 16 at 3:19 PM
	Amazon shelves plans to sell, distribute drugs to hospitals - CNBC finance.yahoo.com - April 16 at 3:19 PM
	CVS Health Expands Safe Drug Disposal at CVS Pharmacy Locations in West Virginia to Help Combat Opioid Abuse finance.yahoo.com - April 16 at 3:19 PM
	Drug distributor and drugstore stocks rally after Amazon shelves plan to sell to hospitals finance.yahoo.com - April 16 at 3:19 PM
	CVS stock spikes with news that Amazon will stay away from shipping drugs finance.yahoo.com - April 16 at 3:19 PM
	CVS Health Appoints Kevin Hourican as President of CVS Pharmacy finance.yahoo.com - April 16 at 3:19 PM
	Amazon Report Sends CVS, Walgreens, These Drug Distributors Soaring finance.yahoo.com - April 16 at 3:19 PM
	Drug players’ shares spike on report that Amazon no longer plans to sell pharmaceuticals finance.yahoo.com - April 16 at 3:19 PM
	CVS Health Teams Up with Job Corps to Enhance Workforce Development Opportunities for Aspiring Pharmacy Technicians www.prnewswire.com - April 16 at 8:06 AM